Ocular Therapeutix Inc (OCUL)
Healthcare
Biotechnology
8.40 $
+2.8%
vs. previous close
Closing price · As of: 3. Aug 2026
Ocular Therapeutix Inc (OCUL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 671 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 162 | 252 | 539 | 517 | 490 | 458 | 406 | 451 | 411 | 808 | 733 | 671 | |
| 141 | 232 | 520 | 499 | 473 | 441 | 388 | 433 | 387 | 782 | 706 | 644 | |
| 111 | 196 | 483 | 460 | 427 | 392 | 350 | 391 | 345 | 737 | 667 | 599 | |
| 111 | 196 | 483 | 460 | 427 | 392 | 350 | 391 | 345 | 737 | 667 | 599 | |
| 24 | 26 | 27 | 30 | 30 | 32 | 25 | 30 | 31 | 31 | 24 | 30 | |
| 2.3 | 2.3 | 2.6 | 2.5 | 2.4 | 3.0 | 3.3 | 3.0 | 3.5 | 3.6 | 3.7 | 3.8 | |
| 155 | 161 | 131 | 139 | 138 | 143 | 140 | 145 | 153 | 154 | 151 | 151 | |
| 35 | 35 | 24 | 30 | 36 | 41 | 38 | 43 | 49 | 51 | 48 | 49 | |
| 1.9 | 1.6 | 1.5 | 1.7 | 1.7 | 1.9 | 2.2 | 2.6 | 2.8 | 2.8 | 3.2 | 3.1 | |
| 4.0 | 4.4 | 6.5 | 3.7 | 4.0 | 4.2 | 4.6 | 5.9 | 6.3 | 4.2 | 8.0 | 7.0 | |
| 74 | 75 | 66 | 67 | 68 | 69 | 69 | 70 | 71 | 71 | 72 | – | |
| 7.9 | 91 | 408 | 378 | 352 | 315 | 266 | 306 | 258 | 654 | 582 | 520 | |
| -668 | -698 | -762 | -806 | -843 | -891 | -955 | -1,023 | -1,092 | -1,157 | -1,246 | -1,324 | |
| 85 | 109 | 132 | 166 | 167 | 168 | 169 | 173 | 184 | 223 | 224 | 225 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.